What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years
Migration can change the demographic dynamics of host populations in terms of communicable diseases in destination countries. This is a potential public health challenge for the health authorities. Hepatitis B virüs (HBV) and hepatitis C virüs (HCV) infections can lead to the development of chronic...
Gespeichert in:
| Veröffentlicht in: | Viral hepatit dergisi 2022-08, Vol.28 (2), p.55-60 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 60 |
|---|---|
| container_issue | 2 |
| container_start_page | 55 |
| container_title | Viral hepatit dergisi |
| container_volume | 28 |
| creator | Çömez, Mehmet Selim Bal, Tayibe Çabalak, Mehmet |
| description | Migration can change the demographic dynamics
of host populations in terms of communicable diseases in
destination countries. This is a potential public health challenge
for the health authorities. Hepatitis B virüs (HBV) and hepatitis
C virüs (HCV) infections can lead to the development of chronic
liver diseases, cirrhosis and hepatocellular carcinoma, whereas
human immunodeficiency virus (HIV) infection can lead to the
development of serious opportunistic diseases. The aim of this
study was to evaluate the seroprevalence of HBV, HCV and HIV
in Syrian refugees and Turkish patients who were evaluated
preoperatively in our hospital.
Materials and Methods: Hepatitis B surface antigen (HBsAg),
hepatitis B surface antibody (anti-HBs), hepatitis B core antibody,
anti-HCV and anti-HIV results of Syrian refugee and Turkish
patients who applied to surgical clinics approximately 2011-2021
were retrospectively reviewed.
Results: The study comprised 54,446 patients: Turkish patient
group (n=20569) and Syrian refugee patient group (n=33877).
The Syrian refugee patients had a significantly higher HBsAg
seropositivity rate and a significantly lower anti-HBs seropositivity
rate than the Turkish patients (p=0.002 and p |
| doi_str_mv | 10.4274/vhd.galenos.2022.2021-9-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_ideal</sourceid><recordid>TN_cdi_proquest_journals_2833278718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2833278718</sourcerecordid><originalsourceid>FETCH-LOGICAL-c247t-1c2cfde4ce72685ae445256677e2957f228bb589cbe8c27fd6d3fb2a5118e3203</originalsourceid><addsrcrecordid>eNpFkcGO0zAURS0EEtXM_MNDbFiQTvxsx8kKlVJopUozokMRK8tJXtqgjF3spFL_gM8mUUdic9_iHd27OIy94-lcopb352M9P9iOnI9zTBGn4EmR8FdshlzqBAtRvGYzLlKdFFLyt-wuxrZMpdSZVFrN2N-fR9tDG6E_EiyHEMj1sGv7wfatd-AbWH_ef4T1cg_W1bDe7GFHwZ8CnafhimDx7N0BdpfQWgffqRkORPETPI4FY1eE1QiObVTDYyB_ojA-ztRd4OFMAZ7IwS-yId6yN43tIt293Bv24-vqablOtg_fNsvFNqlQ6j7hFVZNTbIijVmuLEmpUGWZ1oSF0g1iXpYqL6qS8gp1U2e1aEq0ivOcBKbihr2_9p6C_zNQ7M1vPwQ3ThrMhUCda56P1Icr1dZkO--61tF_cPNltdgangkt1IgWV7QKPsZAjTmF9tmGi-GpmTSZUZN50WQmTVNwUxgu_gH5N4mJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2833278718</pqid></control><display><type>article</type><title>What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years</title><source>Alma/SFX Local Collection</source><creator>Çömez, Mehmet Selim ; Bal, Tayibe ; Çabalak, Mehmet</creator><contributor>Tabak,Fehmi Ömer</contributor><creatorcontrib>Çömez, Mehmet Selim ; Bal, Tayibe ; Çabalak, Mehmet ; Tabak,Fehmi Ömer</creatorcontrib><description>Migration can change the demographic dynamics
of host populations in terms of communicable diseases in
destination countries. This is a potential public health challenge
for the health authorities. Hepatitis B virüs (HBV) and hepatitis
C virüs (HCV) infections can lead to the development of chronic
liver diseases, cirrhosis and hepatocellular carcinoma, whereas
human immunodeficiency virus (HIV) infection can lead to the
development of serious opportunistic diseases. The aim of this
study was to evaluate the seroprevalence of HBV, HCV and HIV
in Syrian refugees and Turkish patients who were evaluated
preoperatively in our hospital.
Materials and Methods: Hepatitis B surface antigen (HBsAg),
hepatitis B surface antibody (anti-HBs), hepatitis B core antibody,
anti-HCV and anti-HIV results of Syrian refugee and Turkish
patients who applied to surgical clinics approximately 2011-2021
were retrospectively reviewed.
Results: The study comprised 54,446 patients: Turkish patient
group (n=20569) and Syrian refugee patient group (n=33877).
The Syrian refugee patients had a significantly higher HBsAg
seropositivity rate and a significantly lower anti-HBs seropositivity
rate than the Turkish patients (p=0.002 and p<0.001, respectively).
The anti-HCV and anti-HIV seropositivity rates were similar. The
annual preoperative prevalence of HBsAg seropositivity in the
Syrian refugee patients tended to significantly decrease gradually
from 2011 to 2021 (p<0.001 for ≤30 and p=0.001 for >30 years old). Conclusion: Although HBV seroprevalence gradually decreases
and HCV and HIV seroprevalence is low; screening, information
and treatment programs should be given due importance because
of the serious disease potential and preventable conditions with
precautions. Additionally, preoperative screening of refugee
patients coming for major surgery may be important for the safety
of healthcare professionals</description><identifier>ISSN: 1307-9441</identifier><identifier>EISSN: 2147-2939</identifier><identifier>DOI: 10.4274/vhd.galenos.2022.2021-9-1</identifier><language>eng</language><publisher>Ankara: Viral Hepatitle Savaşım Derneği</publisher><subject>Age groups ; Antibodies ; Hepatitis B ; Hepatitis C ; HIV ; Hospitals ; Human immunodeficiency virus ; Immune system ; Infectious diseases ; Kemal, Mustafa ; Liver cancer ; Migration ; Patients ; Refugees ; Serology ; Tıp</subject><ispartof>Viral hepatit dergisi, 2022-08, Vol.28 (2), p.55-60</ispartof><rights>2022. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c247t-1c2cfde4ce72685ae445256677e2957f228bb589cbe8c27fd6d3fb2a5118e3203</cites><orcidid>0000-0003-1148-2247 ; 0000-0002-5315-122X ; 0000-0003-0821-5148</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><contributor>Tabak,Fehmi Ömer</contributor><creatorcontrib>Çömez, Mehmet Selim</creatorcontrib><creatorcontrib>Bal, Tayibe</creatorcontrib><creatorcontrib>Çabalak, Mehmet</creatorcontrib><title>What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years</title><title>Viral hepatit dergisi</title><description>Migration can change the demographic dynamics
of host populations in terms of communicable diseases in
destination countries. This is a potential public health challenge
for the health authorities. Hepatitis B virüs (HBV) and hepatitis
C virüs (HCV) infections can lead to the development of chronic
liver diseases, cirrhosis and hepatocellular carcinoma, whereas
human immunodeficiency virus (HIV) infection can lead to the
development of serious opportunistic diseases. The aim of this
study was to evaluate the seroprevalence of HBV, HCV and HIV
in Syrian refugees and Turkish patients who were evaluated
preoperatively in our hospital.
Materials and Methods: Hepatitis B surface antigen (HBsAg),
hepatitis B surface antibody (anti-HBs), hepatitis B core antibody,
anti-HCV and anti-HIV results of Syrian refugee and Turkish
patients who applied to surgical clinics approximately 2011-2021
were retrospectively reviewed.
Results: The study comprised 54,446 patients: Turkish patient
group (n=20569) and Syrian refugee patient group (n=33877).
The Syrian refugee patients had a significantly higher HBsAg
seropositivity rate and a significantly lower anti-HBs seropositivity
rate than the Turkish patients (p=0.002 and p<0.001, respectively).
The anti-HCV and anti-HIV seropositivity rates were similar. The
annual preoperative prevalence of HBsAg seropositivity in the
Syrian refugee patients tended to significantly decrease gradually
from 2011 to 2021 (p<0.001 for ≤30 and p=0.001 for >30 years old). Conclusion: Although HBV seroprevalence gradually decreases
and HCV and HIV seroprevalence is low; screening, information
and treatment programs should be given due importance because
of the serious disease potential and preventable conditions with
precautions. Additionally, preoperative screening of refugee
patients coming for major surgery may be important for the safety
of healthcare professionals</description><subject>Age groups</subject><subject>Antibodies</subject><subject>Hepatitis B</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Immune system</subject><subject>Infectious diseases</subject><subject>Kemal, Mustafa</subject><subject>Liver cancer</subject><subject>Migration</subject><subject>Patients</subject><subject>Refugees</subject><subject>Serology</subject><subject>Tıp</subject><issn>1307-9441</issn><issn>2147-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpFkcGO0zAURS0EEtXM_MNDbFiQTvxsx8kKlVJopUozokMRK8tJXtqgjF3spFL_gM8mUUdic9_iHd27OIy94-lcopb352M9P9iOnI9zTBGn4EmR8FdshlzqBAtRvGYzLlKdFFLyt-wuxrZMpdSZVFrN2N-fR9tDG6E_EiyHEMj1sGv7wfatd-AbWH_ef4T1cg_W1bDe7GFHwZ8CnafhimDx7N0BdpfQWgffqRkORPETPI4FY1eE1QiObVTDYyB_ojA-ztRd4OFMAZ7IwS-yId6yN43tIt293Bv24-vqablOtg_fNsvFNqlQ6j7hFVZNTbIijVmuLEmpUGWZ1oSF0g1iXpYqL6qS8gp1U2e1aEq0ivOcBKbihr2_9p6C_zNQ7M1vPwQ3ThrMhUCda56P1Icr1dZkO--61tF_cPNltdgangkt1IgWV7QKPsZAjTmF9tmGi-GpmTSZUZN50WQmTVNwUxgu_gH5N4mJ</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Çömez, Mehmet Selim</creator><creator>Bal, Tayibe</creator><creator>Çabalak, Mehmet</creator><general>Viral Hepatitle Savaşım Derneği</general><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IEBAR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0003-1148-2247</orcidid><orcidid>https://orcid.org/0000-0002-5315-122X</orcidid><orcidid>https://orcid.org/0000-0003-0821-5148</orcidid></search><sort><creationdate>20220801</creationdate><title>What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years</title><author>Çömez, Mehmet Selim ; Bal, Tayibe ; Çabalak, Mehmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c247t-1c2cfde4ce72685ae445256677e2957f228bb589cbe8c27fd6d3fb2a5118e3203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age groups</topic><topic>Antibodies</topic><topic>Hepatitis B</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Immune system</topic><topic>Infectious diseases</topic><topic>Kemal, Mustafa</topic><topic>Liver cancer</topic><topic>Migration</topic><topic>Patients</topic><topic>Refugees</topic><topic>Serology</topic><topic>Tıp</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Çömez, Mehmet Selim</creatorcontrib><creatorcontrib>Bal, Tayibe</creatorcontrib><creatorcontrib>Çabalak, Mehmet</creatorcontrib><collection>CrossRef</collection><collection>Idealonline online kütüphane - Journals</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Viral hepatit dergisi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Çömez, Mehmet Selim</au><au>Bal, Tayibe</au><au>Çabalak, Mehmet</au><au>Tabak,Fehmi Ömer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years</atitle><jtitle>Viral hepatit dergisi</jtitle><date>2022-08-01</date><risdate>2022</risdate><volume>28</volume><issue>2</issue><spage>55</spage><epage>60</epage><pages>55-60</pages><issn>1307-9441</issn><eissn>2147-2939</eissn><abstract>Migration can change the demographic dynamics
of host populations in terms of communicable diseases in
destination countries. This is a potential public health challenge
for the health authorities. Hepatitis B virüs (HBV) and hepatitis
C virüs (HCV) infections can lead to the development of chronic
liver diseases, cirrhosis and hepatocellular carcinoma, whereas
human immunodeficiency virus (HIV) infection can lead to the
development of serious opportunistic diseases. The aim of this
study was to evaluate the seroprevalence of HBV, HCV and HIV
in Syrian refugees and Turkish patients who were evaluated
preoperatively in our hospital.
Materials and Methods: Hepatitis B surface antigen (HBsAg),
hepatitis B surface antibody (anti-HBs), hepatitis B core antibody,
anti-HCV and anti-HIV results of Syrian refugee and Turkish
patients who applied to surgical clinics approximately 2011-2021
were retrospectively reviewed.
Results: The study comprised 54,446 patients: Turkish patient
group (n=20569) and Syrian refugee patient group (n=33877).
The Syrian refugee patients had a significantly higher HBsAg
seropositivity rate and a significantly lower anti-HBs seropositivity
rate than the Turkish patients (p=0.002 and p<0.001, respectively).
The anti-HCV and anti-HIV seropositivity rates were similar. The
annual preoperative prevalence of HBsAg seropositivity in the
Syrian refugee patients tended to significantly decrease gradually
from 2011 to 2021 (p<0.001 for ≤30 and p=0.001 for >30 years old). Conclusion: Although HBV seroprevalence gradually decreases
and HCV and HIV seroprevalence is low; screening, information
and treatment programs should be given due importance because
of the serious disease potential and preventable conditions with
precautions. Additionally, preoperative screening of refugee
patients coming for major surgery may be important for the safety
of healthcare professionals</abstract><cop>Ankara</cop><pub>Viral Hepatitle Savaşım Derneği</pub><doi>10.4274/vhd.galenos.2022.2021-9-1</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1148-2247</orcidid><orcidid>https://orcid.org/0000-0002-5315-122X</orcidid><orcidid>https://orcid.org/0000-0003-0821-5148</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1307-9441 |
| ispartof | Viral hepatit dergisi, 2022-08, Vol.28 (2), p.55-60 |
| issn | 1307-9441 2147-2939 |
| language | eng |
| recordid | cdi_proquest_journals_2833278718 |
| source | Alma/SFX Local Collection |
| subjects | Age groups Antibodies Hepatitis B Hepatitis C HIV Hospitals Human immunodeficiency virus Immune system Infectious diseases Kemal, Mustafa Liver cancer Migration Patients Refugees Serology Tıp |
| title | What is the Current Situation of HBV, HCV and HIV Seroprevalence Among Syrian Refugees? Patients Evaluated Preoperatively Over Ten Years |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A39%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_ideal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20is%20the%20Current%20Situation%20of%20HBV,%20HCV%20and%20HIV%20Seroprevalence%20Among%20Syrian%20Refugees?%20Patients%20Evaluated%20Preoperatively%20Over%20Ten%20Years&rft.jtitle=Viral%20hepatit%20dergisi&rft.au=%C3%87%C3%B6mez,%20Mehmet%20Selim&rft.date=2022-08-01&rft.volume=28&rft.issue=2&rft.spage=55&rft.epage=60&rft.pages=55-60&rft.issn=1307-9441&rft.eissn=2147-2939&rft_id=info:doi/10.4274/vhd.galenos.2022.2021-9-1&rft_dat=%3Cproquest_ideal%3E2833278718%3C/proquest_ideal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2833278718&rft_id=info:pmid/&rfr_iscdi=true |